FDA Issues New Safety Warning on Rare Cancers Linked to Breast Implants
The U.S. Food and Drug Administration (FDA) has issued a new warning about rare cases of certain cancers, including squamous cell carcinoma (SCC) and various lymphomas, linked to breast implants.
In a safety communication notice posted on Sept. 8, the FDA said it had received reports of cancers found in the scar tissue, or capsule, that forms around breast implants.
SCC is the second most common form of skin cancer, according to the Mayo Clinic, and occurs in the skin’s squamous cells, which construct the middle and outer layer of the skin. Lymphomas refer to cancer of the lymphatic system….